Kazuyoshi Kon

8PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersNutritional epidemiologyPacific Peoples theory of change models for healthCancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

|Jan 08, 2026
Clinical Outcomes and Transitional Care Following Endoscopic Variceal Treatment in Pediatric Portal Hypertension.

Akira Uchiyama, Shunhei Yamashina, Satoshi Sakuma

|Dec 31, 2025
Post-COVID-19 Changes in Body Composition and Adiposity in Patients With Chronic Liver Disease: A Longitudinal Study From Japan.

Akira Uchiyama, Kazuyoshi Kon, Masahiro Tada

|Nov 03, 2023
Hepatic steatosis and skeletal muscle alterations during the COVID-19 lockdown in a cohort of patients with chronic liver disease in Japan.

Akira Uchiyama, Kazuyoshi Kon, Satoshi Sakuma

|Jan 21, 2022
Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease.

Maki Morinaga, Kazuyoshi Kon, Akira Uchiyama

|Feb 22, 2021
Proposal of Stroop test cut-off values as screening for neuropsychological impairments in cirrhosis: A Japanese multicenter study.

Yasuteru Kondo, Motoh Iwasa, Hideto Kawaratani

Pageof 2